Blue Rock Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Blue Rock Wealth Management's ABBV Position: Q2 2026 in Review
Blue Rock Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,515 shares worth $375K. The position accounts for 0.21% of the portfolio, ranked #69.
Blue Rock Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Blue Rock Wealth Management held 1,515 shares of AbbVie worth $375K as of Q2 2026.
- Blue Rock Wealth Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.21% of Blue Rock Wealth Management's portfolio in Q2 2026, its #69 holding.
- Blue Rock Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
- 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Blue Rock Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.